Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Regeneron Pharmaceuticals, Inc. REGN

Set alert

Price alert · REGN

All alert types
972.66 USD +11.40 +1.19%

As of Nov 3, 10:05 AM ET

Bid
970.28 × 1
Ask
972.76 × 1
953.00 Day range 972.79
600.66 52-week range 971.53
YTD
+26.01%
1 year
+51.45%
Open
956.28
Prev close
961.26
Mkt cap
100.63B
Vol
133.95K
Avg vol
746.73K
EPS
45.24
P/E
21.50
Div yield
0.46%
More statistics
Low
953.00
High
972.79
Forward P/E
13.72
Beta
0.10
Short ratio
2.78
Inst. own
93.25%
Dividend
3.76
Ex-div date
Nov 19, 2026
Earnings
Jan 28, 2027
50-d avg
793.30
200-d avg
737.54
1y target
961.96

MAX chart

Chart tools
Interval
1m5m15m30m

Signals (143)
NameDateAgo
SMA: BullishAug 1, 20263 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BearishMay 1, 20266 months ago
MACD: Buy SignalDec 1, 202511 months ago
SMA: BullishOct 1, 20251 year ago
SMA: BearishNov 1, 20242 years ago
SMA: BearishOct 1, 20242 years ago
MACD: Sell SignalOct 1, 20242 years ago
RSI: OverboughtJun 1, 20242 years ago
RSI: OverboughtJan 1, 20242 years ago
MACD: Buy SignalNov 1, 20233 years ago
MACD: Sell SignalOct 1, 20233 years ago
SMA: BullishAug 1, 20233 years ago
MACD: Buy SignalAug 1, 20233 years ago
MACD: Sell SignalJun 1, 20233 years ago
SMA: BearishMay 1, 20233 years ago
MACD: Buy SignalOct 1, 20224 years ago
SMA: BullishSep 1, 20224 years ago
SMA: BearishJun 1, 20224 years ago
MACD: Sell SignalJun 1, 20224 years ago

Newest 20 of 143.

Analyst view

Consensus: buy

Buy
Price target (mean) 961.96 -1.1% downside
Target (low)
730.00
Target (mean)
961.96
Target (high)
1,175.00
Ratings (0m) 28 19 buy · 8 hold · 1 sell
  • Strong buy4
  • Buy15
  • Hold8
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 28
  • 1 month ago 28
  • 2 months ago 27
  • 3 months ago 28

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

REGN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter25.0717.70 – 30.4411.44+119.1%5.84B+50.5%22
Next quarter15.339.56 – 18.809.47+61.9%4.57B+26.8%9
Current year67.5056.63 – 74.5344.31+52.3%17.60B+22.7%25
Next year60.6152.17 – 73.7658.59+3.5%19.82B+12.6%10

Upgrades and downgrades

The latest rating changes

REGN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026Leerink PartnersMaintainedMarket PerformMarket Perform
Nov 2, 2026BernsteinMaintainedMarket PerformMarket Perform
Nov 2, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Nov 2, 2026Truist SecuritiesMaintainedBuyBuy
Nov 2, 2026RBC CapitalMaintainedSector PerformSector Perform
Nov 2, 2026GuggenheimMaintainedBuyBuy
Nov 2, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Nov 2, 2026Evercore ISI GroupMaintainedOutperformOutperform
Nov 2, 2026Canaccord GenuityMaintainedBuyBuy
Nov 2, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Nov 2, 2026BairdMaintainedNeutralNeutral
Nov 2, 2026B of A SecuritiesMaintainedBuyBuy
Oct 30, 2026JP MorganMaintainedOverweightOverweight
Oct 30, 2026CitigroupMaintainedNeutralNeutral
Oct 28, 2026Canaccord GenuityMaintainedBuyBuy
Oct 21, 2026TD CowenMaintainedBuyBuy
Oct 19, 2026Piper SandlerMaintainedOverweightOverweight
Oct 15, 2026UBSUpgradeNeutralBuy
Oct 8, 2026RBC CapitalMaintainedSector PerformSector Perform
Oct 7, 2026Truist SecuritiesMaintainedBuyBuy
Oct 7, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Oct 6, 2026JP MorganMaintainedOverweightOverweight
Oct 1, 2026JefferiesMaintainedBuyBuy
Oct 1, 2026Argus ResearchUpgradeHoldBuy
Sep 29, 2026RBC CapitalReiteratedSector PerformSector Perform
Sep 10, 2026HSBCMaintainedBuyBuy
Aug 17, 2026Leerink PartnersMaintainedMarket PerformMarket Perform
Aug 3, 2026CitigroupMaintainedNeutralNeutral
Aug 3, 2026GuggenheimMaintainedBuyBuy
Jul 31, 2026RBC CapitalMaintainedSector PerformSector Perform